
Klotho Neurosciences, Inc.
KLTONASDAQHealthcare
$0.38
$-0.03(-7.10%)
Market Cap$20079881
P/E Ratio—
52W High$3.91
52W Low$0.114
Klotho Neurosciences, Inc. (KLTO) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · KLTO · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Operations | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Investing Activities | ||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | $0.00B | ($0.00B) | $0.00B |
| Financing Activities | ||||
| Common Stock Repurchased | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | ||||
| Free Cash Flow | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| FCF Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Klotho Neurosciences, Inc. data
About Klotho Neurosciences, Inc. (KLTO) Cash Flow Statement
Klotho Neurosciences, Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2024 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
KLTO · 4 questionsKlotho Neurosciences, Inc. generated free cash flow of ($0.00B) for 2024, down 566.2% year-over-year.
KLTO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10